Эпизоды
-
In the latest episode of the Brain Talks podcast, Sam Pauly is joined by three expert guests: Karen Carr from AbbVie, Dr. Reto Agosti of the Zurich Headache Center, and Frédéric Destrebecq, Executive Director of the European Brain Council to discuss the challenges and opportunities in migraine care, exploring both clinical and policy perspectives.
Together, they shed light on the barriers to effective diagnosis and treatment, the societal and economic impacts of migraines, and innovative solutions paving the way for better care. The discussion highlights the significant delays many patients face in receiving a proper diagnosis, often exacerbated by stigma and misperceptions about migraines. The conversation also underscores the immense burden migraines place on individuals, healthcare systems, and economies, calling for greater policy prioritization.
Tune in to learn how the brain health community is breaking barriers and driving meaningful change for people living with migraines. -
As the EU Health Technology Assessment (HTA) landscape transforms with the upcoming Joint Clinical Assessment (JCA), what does this mean for timely access to innovative therapies and reducing duplication of efforts across Member States?
In this episode, Frédéric Destrebecq, Executive Director of the European Brain Council, sat down with Dr. Dimitrios Georgiopoulos, Senior Vice President and Global Franchise Head for Neurology & Immunology at Merck Healthcare, to discuss the opportunities and challenges of the new Health Technology Assessment Regulation, particularly for orphan and neurological treatments. Join us to explore how this new framework aims to harmonize methodologies, empower patient engagement, and shape a collaborative future for healthcare across the EU. -
Пропущенные эпизоды?
-
Neurodegenerative disorders have a huge societal burden and heavily impact the lives of those affected. Artificial intelligence (AI) in healthcare is a booming field: the development of computer programs and systems able to emulate tasks normally requiring human intelligence such as recognizing patterns, taking decisions, evaluating and predicting is set to revolutionize the prevention and care of people with neurodegenerative disorders.
In this Brain Talks episode, Sam Pauly is joined by Dr Alessandro Guazzo, Postdoctoral Fellow at Carnegie Mellon University and Dr Ira Haraldsen, Primary investigator and Head of the Cognitive Health Research group at the Oslo University Hospital. -
Welcome to Season 4 of Brain Talks!
In this first episode, join our host Sam Pauly with special guests: Lisa Burke, Master of Ceremony for the 4th edition of the Brain Innovation Days, and Frédéric Destrebecq, Executive Director of the European Brain Council.
Discover exclusive insights on the event’s brand new theme, “Navigating the Brain Across a Lifetime,” learn more about the programme, but also its key sessions, new interactive experiences, and much more! -
The increasing number of people living with two or more chronic disorders (multimorbidities) poses an urgent need to better understand underlying mechanisms for better prevention and care throughout the life course. Somatic disorders e.g., type 2 diabetes and brain disorders e.g., Alzheimer’s disorder often co-occur. If a single molecule was the key to some of the greatest health challenges of our time, what would tomorrow look like?
The EU-funded PRIME project aims to unravel the insulin-dependent mechanisms underlying both somatic conditions (e.g., type 2 diabetes, obesity, metabolic syndrome) and brain disorders (e.g., Alzheimer’s disease, obsessive-compulsive disorder, autism spectrum disorders).
In this new Brain Talks episode on the integration of mental and somatic health, Sam Pauly sat down with two partners in this EU-funded project PRIME: Silke Matura, Group Leader at the Goethe University Hospital, and Simone Macri, Researcher at the Italian National Institute of Health. -
The Covid-19 pandemic shed a crude light on how instrumental research and innovation are in the European Union. This crisis revealed significant disparities and fractures between Member States. More importantly, patients living with neurological or mental disorders were heavily impacted by the pandemic, and faced tremendous challenges to maintain their access to care and to meet their medical needs.
In this episode, Frederic Destrebecq, Executive Director of the European Brain Council, Christian Suojanen, Founder & CEO of Broadreach Global, and Professor Michel Goldman, renowned medical doctor and researcher, discuss the post-pandemic European landscape, and address the major challenges and opportunities for brain research and innovation in the EU.
From fostering a collaborative climate within the wider brain community to an ambitious European Brain Research and Innovation Plan, join our journey on what it takes to make brain research and innovation a European priority for the 21st century. -
This Brain Talks episode on Urban Environment and Brain Health features two projects on brain health, funded by the European Union under the same main programme (H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being): BRAINTEASER and eMOTIONAL Cities.
Evidence shows that environmental factors may influence both the aetiology and the progression of a number of brain conditions. Through cost-effective sensors and apps, a comprehensive analysis of clinical, lifestyle and environmental data and predictive/preventive AI models for patient stratification and disease progression, BRAINTEASER aims to better inform people living with MS and ALS and support clinical decision making in 4 urban areas: Madrid, Turin, Lisbon and Pavia.
Urban living is associated to an increase in mood and anxiety disorders, drugs addiction and risk of schizophrenia and psychosis. Through urban stress research, emotional mapping, urban prevention and therapy research, eMOTIONAL Cities aims to explore how urban planning and design could positively impact brain health in 4 cities: Lisbon, Copenhagen, London and Lansing. -
Despite the burden, migraine is not consistently recognized in health policy. However, countries are making progress and establishing a way forward for patients.
In the latest Brain Talks episode, Sam Pauly sat down with Dawn Carlson, AbbVie's Vice-President of Neuroscience Clinical Development, and Alessandra Sorrentino, migraine patient and representative of Alleanza Cefalalgici, to discuss promising developments in migraine care, management, and policy prioritization.
This episode was recorded in partnership with AbbVie. -
In this third episode of Brain Talks | Season 3, Alice Medialia (Columbia University), Péter Kéri (GAMIAN-Europe), and John Saunders (EUFAMI) sat down with Sam Pauly to share some thoughts and advices on how to ensure the meaningful engagement of patients with lived experiences of mental health conditions.
In partnership with Boehringer Ingelheim, this episode was recorded live from the third edition of the Brain Innovation Days -
Join us for the second episode of this new season of Brain Talks, where Dimitrios Georgiopoulos, Global Business Franchise Head for Neurology and Immunology at Merck Healthcare, delves into the world of Multiple Sclerosis (MS) care.Discover Merck's patient-centered approach and explore the challenges and opportunities for young people living with MS in the EU. With 2.9 million people affected, this is a conversation that impacts us all.
-
Brain Talks are back for a third season!
Join us in unveiling the highly anticipated 2023 edition of the Brain Innovation Days with Prof. Suzanne Dickson, President of the European Brain Council, and Frédéric Destrebecq, Executive Director of EBC. -
Tune in to the new podcast episode to hear Sam Pauly talk with two expert guests Professor Asgeir Jakola, Director of the European Association of Neurosurgical Societies (EANS) Research Fund & Dr Victor Staartjes, a neurosurgery resident at the University Hospital Zurich. They look at how the EANS Research Fund facilitates neurosurgical research across Europe.
-
In today's Brain Talk, we’ll be looking at the role technology currently plays in neurosurgery. We are joined by Dr Pieter Kubben, a neurosurgeon at Maastricht University Medical Center and the founder of the Neuromind App and Dr. Marike Broekman, a neurosurgeon in the Department of Neurosurgery at Leiden University Medical Center. She is the first female board member of the European Association of Neurosurgical Associations or EANS, and her main clinical and research interests focus on Neuro-Oncology and Ethics.
-
We're back from our summer break and our host, Sam Pauly, is delighted to be joined today by Dr Orla Galvin, Executive Director of the European Federation of Neurological Associations (EFNA) to discuss the important role patients play in guiding policy and leading advocacy in the brain space, particularly as the "experts" in their own brain conditions. A common phrase in the community always is, "nothing about us without us", a strong call to decision-makers to ensure that the people most affected by their decisions are involved from the beginning.
Accompanied by Dr Elke De Witte, Head of Project Development at the European Brain Council, Sam explores the importance of patient involvement in policy and advocacy, the challenges and roadblocks faced to do so (and how to overcome them) and innovative approaches for improvement at present and in the future.
For more information, visit http://efna.net/ and braininnovationdays.eu -
We're taking a short summer break! We leave you with a short interview with the Executive Director of the European Brain Council, Frédéric Destrebecq, led by host Sam Pauly. Sam exchanges with Fred on the history and mission behind the birth of the Brain Innovation Days and what to expect at the 2nd in-person event this coming 11-12 October 2022 in Brussels, Belgium.
Take a look at the programme now: https://www.braininnovationdays.eu/programme-2022/
We hope to welcome you in Brussels later this year - wishing you all a great summer and see you soon. -
Today we turn the spotlight to neuroscience in Africa and discuss with leading researchers from the region how the African neuroscience community has come together to identify challenges and opportunities in the region, explore possible solutions, and discover unique and important avenues for research.
We are delighted to welcome Dr Mahmoud Bukar Maina, Research Fellow in Neuroscience at the University of Sussex and Professor Sadiq Yusaf, Board Member of the International Brain Research Organisation (IBRO) Africa Regional Committee and President of the Society of Neuroscientists of Africa (SONA).
Discover more on:
ibro.org/regions/africa-committee
sonafrica.org
braininnovationdays.eu -
Today our host Sam Pauly speaks with a recent recipient of the Federation of European Neuroscience Societies (FENS) European Journal of Neuroscience (EJN) Young Investigator Prize, awarded to early-career researchers in recognition of their outstanding scientific contributions to any area of neuroscience.
We are delighted to welcome Dr Nicolas Renier — who received the prize for his work in mapping neuronal and vascular networks in transparent brains — group leader at the Paris Brain Institute, studying the development of the brain throughout life using cutting-edge imaging methods.
From the European Journal of Neuroscience, the official journal of FENS, we welcome two senior editors: Dr Paola Bovolenta and Dr Antoine Adamantidis.
Find more on braininnovationdays.eu -
We know that the COVID-19 pandemic has had repercussions far and wide, but what impact has it had on Mental Health Services and what work can be done to address some of those needs? That’s exactly what the Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) has been researching through a focused survey.
The report has just been released and here to tell us more about the findings we have Nigel Olisa, Executive Director of GAMIAN-Europe, and Chiara Samele, Director of Informed Thinking with over 20 years of experience in mental health research.
Discover more on braininnovationdays.eu -
Today we’ll be looking at pioneering work that was recently recognised by the European Paediatric Neurology Society (EPNS) and awarded an EPNS Research Prize.
Beta-propeller protein-associated neurodegeneration, commonly known as BPAN, is a rare, progressive and life-limiting neurological disorder beginning in infancy or early childhood. Dr Apostolos Papandreou, from University College London, is leading research into treatments for the disorder which could also have positive implications on more common disorders as well.
To tell us more, we welcome in this episode also Dr Jean-Pierre Lin, EPNS Board Member and President of the British Paediatric Neurology Association.
Discover more on braininnovationdays.eu -
The new season of Brain Talks focuses on Brain in the Life Course, kicking off with a focus on pediatric neurology. We are joined by guest Dr David Gómez-Andrés, a specialist in Child Neurology at the University Hospital of Vall d’Hebron in Barcelona and part of the European Paediatric Neurology Society (EPNS), a society for physicians with a research or clinical interest in Paediatric Neurology.
Dr Gómez-Andrés was awarded the 2021 EPNS Research Prize by the Neuromuscular Working Group for his work on ‘Pattern Recognition Muscle MRI in Early Onset Muscle Disorders: From Previous Works to Future Plans’.
David reported: ‘My plan is to use the award to continue the project of machine learning and data representation in muscle imaging. Probably, we will join this to other sources for hiring a young child neurologist to help us in this project and other ones we have ongoing.’
We also welcomed Professor Thomas Sejersen, a senior consultant and lecturer at Karolinska University Hospital in Stockholm and a Board Member of the EPNS, as a co-discussant.
Discover more on https://www.epns.info/ and https://www.braininnovationdays.eu - Показать больше
